TopFunds

West Pharmaceutical Services

NYSE: WST

Stock price

362.16 USD

(-19.27%) 5 years

Health Care SuppliesMedical - Instruments & Supplies

Insider Transactions

5Y price score: (26)
Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

5Y return: -19.27%
DATE RANGE:
USD PER SHARE

  • Stock price
  • Sales
  • Purchases
  • Stock awards

Transaction History

Trade log
DateActionSharesPriceShare ValueHoldingNameTitleSource
15-sep.-26Sale(2,524)365.0(921,260)21,818Favorite Annette Fofficer: Sr. VP & Chief HR Officerlink
14-sep.-26Sale(2,500)355.0(887,500)21,818Favorite Annette Fofficer: Sr. VP & Chief HR Officerlink
11-sep.-26Sale(2,500)345.0(862,500)21,818Favorite Annette Fofficer: Sr. VP & Chief HR Officerlink
08-sep.-26Award13,879337.84,687,63213,879Lagarde Micheldirector, officer: President and CEOlink
08-sep.-26Award12,088337.84,082,72212,088Lagarde Micheldirector, officer: President and CEOlink
08-sep.-26Award11,081337.83,742,60811,081Lagarde Micheldirector, officer: President and CEOlink
08-sep.-26Award6,200--6,200Lagarde Micheldirector, officer: President and CEOlink
08-sep.-26Award4,950--4,950Lagarde Micheldirector, officer: President and CEOlink
08-sep.-26Award3,600--3,600Lagarde Micheldirector, officer: President and CEOlink
08-sep.-26Sale(2,500)340.8(852,025)16,845Favorite Annette Fofficer: Sr. VP & Chief HR Officerlink

223.8

52-week range

386.0

362.16

Your model inputs

Required return / cost of capital
%
FCFF terminal growth rate
%

Your fair value & Margin of safety

To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

Forecast:

Set price notification

Valuation

Free Cash Flow Yield

Help
FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

1.7 %

Dividend Yield TTM

0.2 %

Market cap $

$ 25,487

Price / Earnings TTM

Help
P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

46.3

Price / Book TTM

8.6

PEG TTM

Help
Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

28.2

Earnings growth and return

LTM

5YR

10YR

Total return (price & dividends)

42.4 %

(18.4) %

353.2 %

Free cash flow per share growth

(19) %

64 %

489.1 %

Earnings per share growth

18.1 %

48.8 %

423.1 %

Dividends

Previous dividend:0.22 per share, Paid, Ex-div date Jul 29, 2026

Analyst ratings

Price Target Low

365

Price Target High

447

Price Target Median

407.5

Buy

12

Hold

3

Sell

1

Financials

all figures in USD Millions except per share data

Periods:

View:

Forecast:

Help

Averages

based on historical growth rates (CAGR) and average margins for last 10 or max, available and up to 10 years.

Analysts

Average Revenue and Net Income forecast estimates from analysts who cover the stock.

Custom

you can edit default forecast based on averages or analysts consensus and use it to calculate fair value based on your assumptions.

ㅤ

Actual
10 year gagr
Estimated
Projected
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
2026
2027
2028
2029
2030
Terminal
FISCAL PERIOD END DATES
SHOW FORECAST VS ACTUAL
01Earnings per share
Help
Diluted EPSLearn more
1.3
1.9
2
2.7
3.2
4.6
8.7
7.7
7.9
6.7
6.8
18%
6.8
7.4
8
8.7
9.4
9.7
02FCF per share
1.1
0.7
1.7
2.4
3.2
3.9
4.3
5.8
5.5
3.8
6.4
19.4%
5.1
5.5
6
6.5
7
7
03Dividends per share
Help
Adjusted for splitsLearn more
0.5
0.5
0.5
0.6
0.6
0.7
0.7
0.7
0.8
0.8
0.9
6.6%
-
-
-
-
-
-
04Dividends payout, %
33.9%
24.9%
26%
20.4%
18.7%
13.9%
7.7%
9.2%
9.6%
12%
12.4%
(9.6)%
-
-
-
-
-
-
05Revenue
$ 1,398
$ 1,509
$ 1,600
$ 1,718
$ 1,844
$ 2,147
$ 2,831
$ 2,886
$ 2,951
$ 2,893
$ 3,074
8.2%
$ 3,326
$ 3,598
$ 3,893
$ 4,212
$ 4,558
$ 4,694
06ㅤ% Change
-
8%
6%
7.4%
7.3%
16.4%
31.9%
1.9%
2.3%
(2)%
6.3%
8.2%
8.2%
8.2%
8.2%
8.2%
8.2%
8.2%
07Net Income
95.6
143.6
150.7
206.9
241.7
346.2
661.8
585.9
593.4
492.7
493.7
17.8%
495.6
536.3
580.2
627.8
679.2
699.6
08ㅤ% Margin
6.8%
9.5%
9.4%
12%
13.1%
16.1%
23.4%
20.3%
20.1%
17%
16.1%
14.9% A
14.9%
14.9%
14.9%
14.9%
14.9%
14.9%
09CFO
212.4
219.4
263.3
288.6
367.2
472.5
584
724
776.5
653.4
754.8
13.5%
677.5
733
793.1
858.1
928.5
956.3
10ㅤ% Of revenue
15.2%
14.5%
16.5%
16.8%
19.9%
22%
20.6%
25.1%
26.3%
22.6%
24.6%
20.4% A
20.4%
20.4%
20.4%
20.4%
20.4%
20.4%
11CAPEX
(131.6)
(170.2)
(130.8)
(104.7)
(126.4)
(174.4)
(253.4)
(284.6)
(362)
(377)
(285.9)
8.1%
(309)
(333.9)
(360.8)
(389.9)
(421.4)
(455.4)
12ㅤ% Change
-
29.3%
(23.2)%
(20)%
20.7%
38%
45.3%
12.3%
27.2%
4.1%
(24.2)%
8.1% A
8.1%
8.1%
8.1%
8.1%
8.1%
8.1%
13FCFF
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities (09) – Capital Expenditures (11)Learn more
80.8
49.2
132.5
183.9
240.8
298.1
330.6
439.4
414.5
276.4
468.9
19.2%
368.5
399.1
432.3
468.2
507.1
500.9
14Total assets
1,695
1,717
1,863
1,592
2,341
2,794
3,314
3,617
3,830
3,643
4,270
9.7%
4,683
5,137
5,634
6,179
6,777
7,433
15ㅤ% Change
-
1.3%
8.5%
(14.5)%
47%
19.3%
18.6%
9.1%
5.9%
(4.9)%
17.2%
9.7%
9.7%
9.7%
9.7%
9.7%
9.7%
9.7%
16Total liabilities
671.2
599.2
582.9
582.6
768.2
939.3
978.4
931.9
948.5
961.1
1,094
5%
1,200
1,316
1,443
1,583
1,736
1,904
17ㅤ% Of assets
39.6%
34.9%
31.3%
36.6%
32.8%
33.6%
29.5%
25.8%
24.8%
26.4%
25.6%
25.6% A
25.6%
25.6%
25.6%
25.6%
25.6%
25.6%
18Shareholders Equity
1,024
1,118
1,280
1,010
1,573
1,855
2,335
2,685
2,881
2,682
3,176
12%
3,483
3,821
4,190
4,596
5,041
5,529
19Net Debt
23.6
25.6
(38.9)
(141.3)
(109.8)
(289.8)
(437.3)
(576.4)
(544.9)
(179.3)
(374.6)
-
-
-
-
-
-
-
20Shares Outstanding
Help
Diluted Weighted-average Shares OutstandingLearn more
73,800
75,000
75,800
75,400
75,400
75,800
76,300
75,800
75,300
73,700
72,700
(0.2)%
72,591
72,482
72,373
72,265
72,156
72,048
21ㅤ% Change
-
1.6%
1.1%
(0.5)%
-
0.5%
0.7%
(0.7)%
(0.7)%
(2.1)%
(1.4)%
(0.2)%
(0.2)%
(0.2)%
(0.2)%
(0.2)%
(0.2)%
(0.2)%
22ROA
5.6%
8.4%
8.1%
13%
10.3%
12.4%
20%
16.2%
15.5%
13.5%
11.6%
-
10.6%
10.4%
10.3%
10.2%
10%
9.4%
23ROE
9.3%
12.9%
11.8%
20.5%
15.4%
18.7%
28.3%
21.8%
20.6%
18.4%
15.5%
-
14.2%
14%
13.9%
13.7%
13.5%
12.7%
24Interest coverage
10.7
33.7
32.4
31.5
37.2
49.3
89.3
100.5
80.8
205
1,029
-
-
-
-
-
-
-
25Dividend Yield
0.8%
0.6%
0.5%
0.6%
0.4%
0.2%
0.2%
0.3%
0.2%
0.3%
0.3%
-
-
-
-
-
-
-
26P/E Ratio
45.3
43.3
48.4
35
46
60.5
52.7
29.9
44.1
48.5
40.3
-
-
-
-
-
-
-
27Stock price range
49-64
55-85
79-102
83-124
95-151
129-302
257-471
209-446
232-412
277-413
190-348
-
-
-
-
-
-
-
28Market Cap
Help
End of Period Market CapLearn more
4,336
6,218
7,292
7,244
11,124
20,937
34,894
17,510
26,163
23,912
19,893
16.5%
6,442
7,049
7,717
8,451
9,258
-
29FCF Yield
1.9%
0.8%
1.8%
2.5%
2.2%
1.4%
1%
2.5%
1.6%
1.2%
2.4%
2.4%
5.7%
5.7%
5.6%
5.5%
5.5%
-
30Average stock price
56.7
70
90.1
103.7
122.9
215.3
364.3
327.6
322.5
345.1
269.1
16.9%
88.7
97.3
106.6
116.9
128.3
-
31 CEO
EG
Eric Green
ML
Michel Lagarde